Loading...
XSTO
RAY B
Market cap819mUSD
Dec 05, Last price  
224.50SEK
1D
-0.22%
1Q
-5.87%
Jan 2017
21.68%
Name

RaySearch Laboratories AB (publ)

Chart & Performance

D1W1MN
XSTO:RAY B chart
P/E
37.82
P/S
6.46
EPS
5.94
Div Yield, %
0.58%
Shrs. gr., 5y
Rev. gr., 5y
9.96%
Revenues
1.19b
+16.62%
69,855,00068,976,00064,705,00062,690,00083,687,000117,728,000126,103,000182,087,000204,470,000285,217,000397,600,000531,468,000585,086,000627,219,000741,584,000651,612,000641,673,000843,648,0001,022,159,0001,192,029,000
Net income
204m
+149.49%
29,142,00036,219,00019,779,00018,223,00030,146,00028,895,00017,007,00019,863,000-20,841,00059,832,00070,209,000151,408,000117,627,00078,523,00050,411,000-9,080,000-47,315,00023,778,00081,572,000203,513,000
CFO
485m
+6.43%
41,393,00030,093,00037,862,00026,045,00049,207,00062,785,00033,852,00087,451,00031,282,00050,273,000111,426,000120,848,000147,481,000178,472,000320,145,000331,508,000238,162,000356,777,000455,931,000485,230,000
Dividend
May 23, 20253 SEK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.
IPO date
May 29, 1990
Employees
375
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT